Clendeninn Neil James
Insider CIK 1442443 · HRTX SVP & Chief Medical Officer · OGXI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2016-05-26 | 2016-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 22,421 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-10-28 | 2015-10-30 | 5,359 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-10-28 | 2015-10-30 | 5,359 | $2.69 | $14.4K | 19,921 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2015-10-12 | 2015-10-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2015-10-12 | 2015-10-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 14,562 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 12,062 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-05-23 | 2013-05-28 | 2,000 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-05-23 | 2013-05-28 | 2,000 | $10.64 | $21.3K | 9,562 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2012-10-18 | 2012-10-19 | 513 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2012-10-18 | 2012-10-19 | 513 | $4.11 | $2.1K | 7,562 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2012-08-03 | 2012-08-07 | 3,702 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2012-08-03 | 2012-08-07 | 3,702 | $4.11 | $15.2K | 7,049 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 4,000 | — | $0 | 4,000 | SEC↗ |